Market Cap | 1.45B | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | - | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 3.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | 7.00% |
Dividend | N/A | Price/Book | EPS next 5Y | - | 52W High Chg | -19.00% | |
Recommedations | - | Quick Ratio | - | Shares Outstanding | 74.17M | 52W Low Chg | 22.00% |
Insider Own | - | ROA | - | Shares Float | - | Beta | - |
Inst Own | 20.37% | ROE | - | Shares Shorted/Prior | 55.66K/13.05K | Price | 18.61 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 196,035 | Target Price | - |
Oper. Margin | - | Earnings Date | - | Volume | 270,431 | Change | -1.95% |
BlackRock Science and Technology Term Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the science and technology sectors. It primarily invests in growth stocks of companies across all market capitalizations. BlackRock Science and Technology Term Trust was formed in June 2019 and is domiciled in the United States.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Kim Tony | Director Director | Sep 19 | Sell | 16.6696 | 22,676 | 378,000 | 152,273 | 09/21/23 |
McClements Kyle | Other Other | Jan 11 | Buy | 17.12 | 391 | 6,694 | 4,686 | 01/13/23 |
Fairbairn Robert W | Director Director | Dec 29 | Buy | 36.3325 | 6,835 | 248,333 | 6,835 | 02/09/22 |